Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Vatreptacog alfa (activated)

EU orphan designation number: EU/3/12/1030
Active ingredient: Vatreptacog alfa (activated)
Indication: Treatment of haemophilia A
Sponsor: Novo Nordisk A/S
Novo Allé, DK-2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/08/2012 Orphan designation EMA/OD/069/12 (2012)5794 of 09/08/2012
08/09/2014 Removal of orphan designation from Community Register